• Skip to content
  • Go to search box
  • Go to site navigation
You are here Home HTB2002May Site menu
HIV i-Base home
HIV positive Professional Advocate News RSS i-Base on Facebook Feedback Donate

HIV Treatment Bulletin

May 2002

Contents

Antiretrovirals

  • Hydroxyurea: in vitro evidence of potency against HIV viral reservoirs
  • Transient increases in viral load are common among people on HAART, finds a study of UK patients
  • Meta-analysis supports triple therapy for HIV infection

PMTCT and maternal health

  • Reduction of mother to child HIV-1 transmission: breastfeeding negates benefits of short course regimens
  • Nevirapine at the centre of MTCT controversy
  • Mothers, orphans, and prevention of paediatric AIDS

Side effects

  • Altered adipocyte differentiation associated with protease inhibitors and lipoatrophy
  • High mortality rate in patients with severe NRTI-associated lactic acidosis
  • Tenofovir adversely affects development in foetal monkeys
  • Tenofovir not toxic to mitochondria in human cell culture

Opportunistic infections and complications

  • HIV infection is a risk factor for external genital warts, study suggests
  • American study finds KS-associated herpesvirus is highly prevalent among gay men

Other news

  • Gilead made misleading and illegal statements about Viread, says FDA
  • Barcelona conference organisers issue nine-point plan of action on global emergency

On the web

  • Incorporating antiretroviral resistance testing into clinical practice
  • Management of co-infection with HIV and TB

PDFs

  • Volume 3 Number 4 May 2002 PDF
HTB RSS

Current issues

  • June 2017
  • April 2017
  • February 2017
  • Back issues

Special report

  • i-Base appeal: we need your help… 24 April 2017

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs

Home

  • i-Base homepage

This site complies with the HONcode standard for trustworthy health information. Verify here.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-Base

About us - Contact - Cookies and privacy - Copyright waiver - Site map - i-Base homepage

107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Fax + 44 (0) 208 616 1250. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Site navigation menu

  • Q and A
  • Phoneline
  • HTB
  • HTB South
  • Guides
  • Training manual
  • Simon Collins' blog
  • Polly Clayden's blog
  • News
  • Publications
  • Other resources
  • Translations
  • Order and subscribe
  • HIV positive people
  • Advocates
  • Professionals
  • HIV transmission and testing
  • HIV meds
  • Pipeline report
  • UK-CAB
  • About us
  • Contact
  • Donate
  • Feedback
  • Glossary
  • Full site map
  • i-Base homepage